Cytokine serum levels in patients infected by human immunodeficiency virus with and without Trypanosoma cruzi coinfection

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 38, Issue 6, 2005, Pages 483-487

  Rocha Rodrigues, Denise Bertulucci ^a,b   Correia, Dalmo ^a   Marra, Mônica Dias ^a   Ramirez Giraldo, Luis Eduardo ^a   Lages Silva, Eliane ^a   Silva Vergara, Mario León ^a   Barata, Cristina Hueb ^a   Rodrigues Jr , Virmondes ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF UBERABA   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Chagas' disease; Cytokine; Trypanosoma cruzi

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOREGULATION; LYMPHOCYTE COUNT; MALE; PARASITEMIA; PROTEIN BLOOD LEVEL; REINFECTION; SUPERINFECTION; TH2 CELL; TRYPANOSOMA CRUZI;

HUMAN IMMUNODEFICIENCY VIRUS; TRYPANOSOMA CRUZI;

EID: 31644449220     PISSN: 00378682     EISSN: 00378682     Source Type: Journal    
DOI: 10.1590/s0037-86822005000600007     Document Type: Article

References (22)

1. Aliberti JCS, Souto JT, Marino APMP, Lanes-vieira J, Teixeira MM, Farber J, Gazzinelli RT, Silva JS. Modulation of chemokine production and inflammatory responses in Interferon-γ and Tumor Necrosis Factor-R1-Deficient Mice during Trypanosoma cruzi infection. American Journal of Pathology 158:1433-1440, 2001.
2. Brener Z, Gazzinelli RT. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. International Archive of Allergy and Immunology 114:103-110, 1997.
3. Chiari E, Dias JCP, Lana M, Chiari CA. Hemocultures for the parasitological diagnosis of human Chagas' disease. Revista da Sociedade Brasileira de Medicina Tropical 22:19-23, 1989.
4. Cohen JE, Tsai EC, Ginsberg HJ, Godes J. Pseudotumoral chagasic meningoencephalitis as the first manifestation of acquired immunodeficiency syndrome. Surgical Neurology 49:324-327,1998.
5. Del Castillo M, Mendoza G, Oviedo J, Perez Bianco RP, Anselmo AE, Silva M. AIDS and Chagas' disease with central nervous system tumor-like lesion. American Journal of Medicine 88:693-694, 1990.
6. Ferreira MS. The acquired immunodeficiency syndrome and endemic disease in Brazil. Revista da Sociedade Brasileira de Medicina Tropical 29:531-535,1996.
7. Ferreira MS. Chagas' disease and immunosuppression. Memórias do Instituto Oswaldo Cruz 94:325-327, 1999.
8. Ferreira MS, Nishioka SA, Rocha A, Silva AM, Ferreira RG, Olivier W, Tostes Jr S. Acute fatal Trypanosoma cruzi meningoencephalitis in a human immunodeficiency virus-positive hemophilic patient. The American Journal of Tropical Medicine and Hygiene 45:723-727, 1991.
9. Ferreira RC, Ianni BM, Abel LCJ, Buck P, Mady C, Kalil J, Cunha-Neto E. Increased plasma levels of Tumor necrosis factor-α in asymptomatic/ "indeterminate" and Chagas' disease cardiomyopathy patients. Memórias do Instituto Oswaldo Cruz 98:704-711, 2003.
10. Gluckstein D, Ciferri F, Ruskin J. Chagas' disease: another cause of cerebral mass in the acquired immunodeficiency syndrome. American Journal of Medicine 92:301-302, 1992.
11. Holt DF, Eickhoff CS. Type 1 immunity provide optimal protection against both mucosal and systemic Trypanosoma cruzi challenges. Infection and Immunity 70:6715-6725, 2002.
12. Kumar S, Tarleton RL. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. Journal of Immunology 166:4596-4603, 2001.
13. Lages-Silva E, Ramirez LE, Silva-Vergara ML, Chiari E. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypanosoma cruzi. Clinical Infectious Diseases 34:118-123, 2002.
14. Morgado MG, Barcellos C, Pina MF, Bastos FI. Human immunodeficiency virus/acquired immunodeficiency syndrome and tropical disease: a Brazilian perspective. Memórias do Instituto Oswaldo Cruz 95:145-151, 2000.
15. Pacheco RS, Ferreira MS, Machado MI, Brito CM, Pires MQ, Da-Cruz AM, Coutinho SG. Chagas' disease and coinfection: genotypic characterization of the Trypanosoma cruzi strain. Memórias do Instituto Oswaldo Cruz 93:165-169, 1998.
16. Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satt GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. New England Journal of Medicine 338:853-860, 1998.
17. Preiser W, Cacopardo B, Nigro L, Braner J, Nunnari A, Doerr HW, Weber B. Immunological findings in HIV-Leishmania coinfection. Intervirology 39:285-288,1996.
18. Ramsdell F, Seaman MS, Miller RE, Kennedy MK, Lynch DH. Differential ability of Th1 and Th2 cells to express Fas ligant and to undergo activation induced cell death. International Immunology 6:1545-1553, 1994.
19. Rocha A, Meneses AC, Silva MA, Ferreira MS, Nishioka SA, Burgarelli MK, Almeida E, Turcano Junior G, Metze K, Lopes ER. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. The American Journal of Tropical Medicine and Hygiene 50: 261-268, 1994.
20. Sartori AM, J Neto E, Nunes EV, Braz LM, Caiaffa-Filho HH, Oliveira OC, Amato-Neto V, Shikanai-Yasuda MA. Trypanosoma cruzi parasitemia in chronic Chagas' disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. Journal of Infectious Disease 186:872-875, 2002.
21. Silva JS, Aliberti JCS, Martins GA, Souza MA, Souto JT, Pádua MA. The role of IL-12 in experimental Trypanosoma cruzi infection. Brazilian Journal of Medical and Biology Research 31:111-115,1998.
22. Ward LS, Guariento ME, Fernandes GA, Maciel RM. Serum cytokines in chronic Chagas' disease. Revista da Sociedade Brasileira de Medicina Tropical 32:285-289, 1999.